DME Capital Management
Latest statistics and disclosures from DME Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GRBK, FLR, CNR, BHF, ACHC, and represent 38.23% of DME Capital Management's stock portfolio.
- Added to shares of these 10 stocks: FBIN (+$123M), VGNT (+$96M), PRMB (+$69M), PYPL (+$62M), WBD (+$60M), PVH (+$39M), SHC (+$37M), CNR (+$34M), CMCSA (+$33M), DCH (+$33M).
- Started 7 new stock positions in VGNT, PRMB, CMCSA, WBD, PVH, FBIN, PYPL.
- Reduced shares in these 10 stocks: VSXY (-$105M), CNC (-$69M), , PTON (-$43M), VSNT (-$40M), SNX (-$26M), WFRD (-$14M), ZIM (-$9.3M), SPB (-$7.6M), GLD (-$6.0M).
- Sold out of its positions in Katapult Holdings, PTON, SLM, VSXY, WFRD, ZIM.
- DME Capital Management was a net buyer of stock by $290M.
- DME Capital Management has $3.9B in assets under management (AUM), dropping by 22.51%.
- Central Index Key (CIK): 0001489933
Tip: Access up to 7 years of quarterly data
Positions held by DME Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for DME Capital Management
DME Capital Management holds 46 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Green Brick Partners (GRBK) | 19.4 | $758M | 9.5M | 80.04 |
|
|
| Fluor Corporation (FLR) | 6.2 | $244M | 4.7M | 52.39 |
|
|
| Core Natural Resources Com Shs (CNR) | 4.7 | $183M | +22% | 2.3M | 80.02 |
|
| Brighthouse Finl (BHF) | 4.6 | $180M | 2.8M | 63.30 |
|
|
| Acadia Healthcare (ACHC) | 3.3 | $130M | -2% | 4.4M | 29.53 |
|
| Penn National Gaming (PENN) | 3.2 | $125M | -3% | 5.9M | 21.36 |
|
| Fortune Brands (FBIN) | 3.1 | $123M | NEW | 2.2M | 54.90 |
|
| PG&E Corporation (PCG) | 2.9 | $112M | 6.6M | 16.82 |
|
|
| Centene Corporation (CNC) | 2.7 | $106M | -39% | 1.7M | 64.19 |
|
| Graphic Packaging Holding Company (GPK) | 2.7 | $105M | +9% | 10M | 10.57 |
|
| SYNNEX Corporation (SNX) | 2.6 | $102M | -20% | 381k | 267.34 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.5 | $98M | 2.9M | 33.88 |
|
|
| Versigent Ordinary Shares (VGNT) | 2.4 | $96M | NEW | 2.3M | 42.01 |
|
| Capri Holdings SHS (CPRI) | 2.3 | $90M | -2% | 4.8M | 18.57 |
|
| Bkv Corp (BKV) | 2.2 | $85M | +14% | 3.1M | 27.36 |
|
| Dht Holdings Shs New (DHT) | 2.1 | $83M | -4% | 5.0M | 16.53 |
|
| Crocs (CROX) | 2.1 | $81M | 669k | 120.64 |
|
|
| Roivant Sciences SHS (ROIV) | 1.9 | $76M | 2.2M | 35.39 |
|
|
| Sotera Health (SHC) | 1.9 | $73M | +100% | 4.1M | 17.75 |
|
| Versant Media Group Com Cl A (VSNT) | 1.8 | $69M | -36% | 1.9M | 36.01 |
|
| Primo Brands Corporation Class A Com Shs (PRMB) | 1.8 | $69M | NEW | 2.8M | 24.44 |
|
| American Axle & Manufact. Holdings (DCH) | 1.7 | $67M | +96% | 12M | 5.42 |
|
| Paypal Holdings (PYPL) | 1.6 | $62M | NEW | 1.4M | 43.18 |
|
| Henry Schein (HSIC) | 1.5 | $60M | +19% | 719k | 83.52 |
|
| Warner Bros Discovery Com Ser A (WBD) | 1.5 | $60M | NEW | 2.2M | 26.66 |
|
| Liberty Global Com Cl A (LBTYA) | 1.4 | $56M | 5.0M | 11.37 |
|
|
| Antero Res (AR) | 1.4 | $55M | +94% | 1.6M | 35.14 |
|
| Stubhub Hldgs Cl A (STUB) | 1.4 | $55M | 4.2M | 12.87 |
|
|
| Resideo Technologies (REZI) | 1.4 | $53M | +7% | 1.7M | 31.10 |
|
| Deckers Outdoor Corporation (DECK) | 1.3 | $50M | +5% | 506k | 99.29 |
|
| Spectrum Brands Holding (SPB) | 1.2 | $48M | -13% | 561k | 85.75 |
|
| Cnh Indl N V SHS (CNH) | 1.2 | $47M | 4.2M | 11.23 |
|
|
| Viatris (VTRS) | 1.1 | $44M | +52% | 2.8M | 15.88 |
|
| Paramount Skydance Corp Com Cl B (PSKY) | 1.0 | $39M | 3.9M | 9.86 |
|
|
| Pvh Corporation (PVH) | 1.0 | $39M | NEW | 521k | 74.26 |
|
| Comcast Corp Cl A (CMCSA) | 0.8 | $33M | NEW | 1.3M | 24.55 |
|
| Slide Ins Hldgs (SLDE) | 0.8 | $33M | 1.7M | 19.37 |
|
|
| Tripadvisor (TRIP) | 0.8 | $32M | +50% | 2.4M | 13.71 |
|
| Spdr Gold Tr Gold Shs (GLD) | 0.8 | $31M | -16% | 83k | 368.38 |
|
| Cigna Corp (CI) | 0.6 | $24M | 88k | 275.68 |
|
|
| Lakefront Biotherapeutics Nv Spon Adr | 0.4 | $15M | 483k | 29.98 |
|
|
| Coya Therapeutics Common Stock (COYA) | 0.3 | $14M | 2.3M | 5.85 |
|
|
| Immunovant (IMVT) | 0.1 | $3.6M | 94k | 38.53 |
|
|
| Gopro Cl A (GPRO) | 0.0 | $1.3M | 1.7M | 0.78 |
|
|
| Gain Therapeutics (GANX) | 0.0 | $1.1M | 566k | 2.03 |
|
|
| Nuvation Bio Com Cl A (NUVB) | 0.0 | $199k | 35k | 5.68 |
|
Past Filings by DME Capital Management
SEC 13F filings are viewable for DME Capital Management going back to 2024
- DME Capital Management 2026 Q2 filed Aug. 14, 2026
- DME Capital Management 2026 Q1 filed May 15, 2026
- DME Capital Management 2025 Q4 filed Feb. 17, 2026
- DME Capital Management 2025 Q3 filed Nov. 14, 2025
- DME Capital Management 2025 Q2 filed Aug. 14, 2025
- DME Capital Management 2025 Q1 filed May 15, 2025
- DME Capital Management 2024 Q4 filed Feb. 14, 2025
- DME Capital Management 2024 Q3 filed Nov. 14, 2024
- DME Capital Management 2024 Q2 filed Aug. 14, 2024
- DME Capital Management 2024 Q1 filed May 15, 2024